Cancer incidence and risk factors after solid organ transplantation.
about
Cutaneous Squamous Cell Carcinomas in Organ Transplant RecipientsCutaneous squamous cell carcinoma and human papillomavirus: is there an association?Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agentsReviewing 15 years of experience with sirolimusMicroenvironmental regulation of tumor progression and metastasisRole of Tregs in Cancer Dormancy or Recurrence.Where are oncofertility and fertility preservation treatments heading in 2016?Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden.Urokinase gene 3'-UTR T/C polymorphism is associated with malignancy and ESRD in idiopathic membranous nephropathy.Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.Cancer Immunoprevention and Public Health.Current status of islet cell replacement and regeneration therapy.De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population studyDeep sequencing extends the diversity of human papillomaviruses in human skin.Point/Counterpoint: low-dose radiation is beneficial, not harmful.Hodgkin lymphoma among US solid organ transplant recipientsComparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage.Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer.Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactionsOncogenic Virus Infections in the General Population and End-stage Renal Disease Patients With Special Emphasis on Kaposi's Sarcoma Associated Herpes Virus (KSHV) in Northeast of Iran.Treating rheumatic patients with a malignancy.Spectrum of cancer risk among US solid organ transplant recipients.Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder.VSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients.Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis.Post-transplant malignancy in liver transplantation: a single center experienceEffect of autoimmune diseases on incidence and survival in subsequent multiple myelomaShifting the paradigm in radiation safety.Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantationMalignancies in a renal transplant population: The St. Michael's Hospital experience.Plasma cell neoplasms in US solid organ transplant recipients.Risk of lymphoma subtypes after solid organ transplantation in the United States.Striking life events associated with primary breast cancer susceptibility in women: a meta-analysis study.Antitumor activity of nivolumab on hemodialysis after renal allograft rejection.Development of hepatocellular carcinoma after long-term immunosuppressive therapy including danazol in a dog.Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer PatientsRisk of Colorectal Cancer After Solid Organ Transplantation in the United States.Biological agents in kidney transplantation: belatacept is entering the field.Why do viruses cause cancer? Highlights of the first century of human tumour virology.
P2860
Q26799460-05791B78-BA6D-4602-B717-0C13953D3506Q27693832-142316E3-FC30-405E-A57F-D34AB0AB938DQ28073524-7392E525-E59A-4FDC-9C55-21BC076DB622Q28080955-509EB7A5-2385-46A2-868B-401481C7CE53Q29615504-0EA67799-11A0-4C9F-B558-CA32934BE03CQ30244203-A9F0BE49-E4ED-40E7-9A34-1D35355BBA40Q30249457-172A9789-E17B-4F93-8ED5-8A6EFFA31482Q31041008-CBC22BBF-1ABA-4D2A-95D1-B4986257D93BQ33562449-6769307F-BE8A-4394-B9B3-76D0CFFD305FQ33575734-12855098-10E4-42C2-8C9B-3C51B4B87CF6Q33646584-B96306A4-32A4-41E6-8A23-52E9E070032AQ33738705-F11299AA-D4DE-4853-809F-FF5C45CBDF80Q33829612-76F76771-EB68-4CBA-86B5-B3991BFEFC4BQ33941956-86B90A61-9692-42C3-A173-B2377FF22A0EQ33944351-A5491362-28B7-4D7B-B177-D770A87D1D10Q34258853-1CB8CF68-03D7-4D45-8CC4-F119B5986DF8Q34396026-582CEDDF-6421-4230-920F-1269421FF6EDQ34417635-C68183C3-95EE-4AD1-A097-80B692F492C5Q34477550-70D84920-FF9B-4658-B839-E3EFACA23FE8Q35226037-72D2731A-8E78-4B2E-816B-9F1F68C4E6F0Q35557863-01DD2C21-402F-4A34-A24E-F2246BE2C66FQ35848186-9908DFCA-4FC7-4D8E-819B-5E8CB4F90532Q35918672-484E104F-87FA-42EF-9429-6DC81DFBC43AQ35941343-743338BC-8054-4BCB-911C-3FA024BE97EDQ36076614-3EE7A0D5-6DD4-4FDD-B9AA-0F771230EB04Q36154140-36669285-E7F0-4543-A33B-6F1A713276CAQ36323304-30741060-4A0B-4268-80CB-205766DE8083Q36478158-3D72EF25-0E32-4FDC-9BBD-084C6B1330C3Q36480011-E40ABC2A-2A5D-45DD-9C69-CCCE24953D15Q36527033-3F02EB4B-B98D-434C-A32E-A40E01D06FA5Q36820830-71916057-455E-4E43-B888-B6255E1AC088Q36913892-50A6E9D4-6D6B-4CF0-8432-A8A66469CBACQ37003308-B73D0408-832E-43F2-8BFF-DC8C26EED4C0Q37116550-E0F665DC-7C5D-4363-A1A5-CA9DF2D831ECQ37346073-83B0447E-0284-4BE2-9628-DB256AB54718Q37393836-421C3982-E7CA-4506-BB5D-40642C720CF8Q37483023-F509C4A7-6635-422A-B558-2127729D10F9Q37568450-FDBEB44E-6076-4A9C-86EF-7BE943DCAED8Q37781355-FF5779CC-209D-4CEF-9496-2E35FE51A64BQ37811898-422BA45A-0E20-4D12-997D-1DF87C111851
P2860
Cancer incidence and risk factors after solid organ transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer incidence and risk factors after solid organ transplantation.
@en
Cancer incidence and risk factors after solid organ transplantation.
@nl
type
label
Cancer incidence and risk factors after solid organ transplantation.
@en
Cancer incidence and risk factors after solid organ transplantation.
@nl
prefLabel
Cancer incidence and risk factors after solid organ transplantation.
@en
Cancer incidence and risk factors after solid organ transplantation.
@nl
P356
P1476
Cancer incidence and risk factors after solid organ transplantation.
@en
P2860
P304
P356
10.1002/IJC.24439
P577
2009-10-01T00:00:00Z